cached image

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Neyman S, Braunewell KH, O'Connell KE, Dev KK, Manahan-Vaughan D. Inhibition of the Interaction Between Group I Metabotropic Glutamate Receptors and PDZ-Domain Proteins Prevents Hippocampal Long-Term Depression, but Not Long-Term Potentiation. Frontiers in Synaptic Neuroscience. 11: 13. PMID 31057390 DOI: 10.3389/fnsyn.2019.00013  0.36
2018 Dutta P, Dargahi L, O'Connell KE, Bolia A, Ozkan B, Sailer AW, Dev KK. A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson's disease. Neuroscience Letters. PMID 29496607 DOI: 10.1016/j.neulet.2018.02.055  0.36
2016 Madill M, Fitzgerald D, O'Connell KE, Dev KK, Shen S, FitzGerald U. In vitro and ex vivo models of multiple sclerosis. Drug Discovery Today. PMID 27265771 DOI: 10.1016/j.drudis.2016.05.018  1
2016 O'Sullivan C, Schubart A, Mir AK, Dev KK. The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures. Journal of Neuroinflammation. 13: 31. PMID 26856814 DOI: 10.1186/s12974-016-0494-x  1
2015 O'Sullivan C, Dev KK. Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling. Journal of Cell Science. 128: 3878-87. PMID 26359302 DOI: 10.1242/jcs.169342  1
2015 O'Connell KE, Thakore J, Dev KK. Increased interleukin 23 (IL23) levels in schizophrenia patients treated with depot antipsychotic medication. Cytokine. 73: 196-8. PMID 25769808 DOI: 10.1016/j.cyto.2014.11.003  1
2015 Rutkowska A, Preuss I, Gessier F, Sailer AW, Dev KK. EBI2 regulates intracellular signaling and migration in human astrocyte. Glia. 63: 341-51. PMID 25297897 DOI: 10.1002/glia.22757  1
2014 O'Connell KE, Frei P, Dev KK. The premium of a big pharma license deal. Nature Biotechnology. 32: 617-9. PMID 25004224 DOI: 10.1038/nbt.2946  1
2014 O'Connell KE, Mok T, Sweeney B, Ryan AM, Dev KK. The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients. Autoimmunity. 47: 505-11. PMID 24974887 DOI: 10.3109/08916934.2014.930734  1
2014 Pritchard AJ, Mir AK, Dev KK. Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures. Plos One. 9: e99444. PMID 24911000 DOI: 10.1371/journal.pone.0099444  1
2014 Sheridan GK, Dev KK. Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations. Scientific Reports. 4: 5051. PMID 24851861 DOI: 10.1038/srep05051  1
2014 Dutta P, O'Connell KE, Ozkan SB, Sailer AW, Dev KK. The protein interacting with C-kinase (PICK1) interacts with and attenuates parkin-associated endothelial-like (PAEL) receptor-mediated cell death. Journal of Neurochemistry. 130: 360-73. PMID 24749734 DOI: 10.1111/jnc.12741  1
2014 O'Connell KE, Thakore J, Dev KK. Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine. Schizophrenia Research. 156: 1-8. PMID 24742875 DOI: 10.1016/j.schres.2014.03.020  1
2014 Elain G, Jeanneau K, Rutkowska A, Mir AK, Dev KK. The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes. Glia. 62: 725-35. PMID 24677511 DOI: 10.1002/glia.22637  1
2014 Muirhead G, Dev KK. The expression of neuronal sorting nexin 8 (SNX8) exacerbates abnormal cholesterol levels. Journal of Molecular Neuroscience : Mn. 53: 125-34. PMID 24362679 DOI: 10.1007/s12031-013-0209-z  1
2014 Shrestha R, Millington O, Brewer J, Dev KK, Bushell TJ. Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways. Neuropharmacology. 76: 184-93. PMID 23831681 DOI: 10.1016/j.neuropharm.2013.06.025  1
2013 Frei P, Dev KK. Drug dealers: $20 trillion of in-licensing payments. Drug Discovery Today. 18: 1027-9. PMID 23973744 DOI: 10.1016/j.drudis.2013.08.011  1
2013 O'Sullivan C, Dev KK. The structure and function of the S1P1 receptor. Trends in Pharmacological Sciences. 34: 401-12. PMID 23763867 DOI: 10.1016/j.tips.2013.05.002  1
2013 O'Connell K, Thakore J, Dev KK. Levels of S100B are raised in female patients with schizophrenia. Bmc Psychiatry. 13: 146. PMID 23705829 DOI: 10.1186/1471-244X-13-146  1
2013 Healy LM, Sheridan GK, Pritchard AJ, Rutkowska A, Mullershausen F, Dev KK. Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes. British Journal of Pharmacology. 169: 1114-29. PMID 23587004 DOI: 10.1111/bph.12207  1
2013 Doucet MV, Levine H, Dev KK, Harkin A. Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1575-84. PMID 23446451 DOI: 10.1038/npp.2013.57  1
2013 Pritchard AJ, Dev KK. The role of sphingosine 1-phosphate receptors in the treatment of demyelinating diseases Future Neurology. 8: 569-581. DOI: 10.2217/fnl.13.32  1
2012 Bolia A, Gerek ZN, Keskin O, Banu Ozkan S, Dev KK. The binding affinities of proteins interacting with the PDZ domain of PICK1. Proteins. 80: 1393-408. PMID 22275068 DOI: 10.1002/prot.24034  1
2012 Doucet MV, Harkin A, Dev KK. The PSD-95/nNOS complex: new drugs for depression? Pharmacology & Therapeutics. 133: 218-29. PMID 22133842 DOI: 10.1016/j.pharmthera.2011.11.005  1
2012 Sheridan GK, Dev KK. S1P1 receptor subtype inhibits demyelination and regulates chemokine release in cerebellar slice cultures. Glia. 60: 382-92. PMID 22108845 DOI: 10.1002/glia.22272  1
2011 Rieker C, Dev KK, Lehnhoff K, Barbieri S, Ksiazek I, Kauffmann S, Danner S, Schell H, Boden C, Ruegg MA, Kahle PJ, van der Putten H, Shimshek DR. Neuropathology in mice expressing mouse alpha-synuclein. Plos One. 6: e24834. PMID 21966373 DOI: 10.1371/journal.pone.0024834  1
2010 Mattes H, Dev KK, Bouhelal R, Barske C, Gasparini F, Guerini D, Mir AK, Orain D, Osinde M, Picard A, Dubois C, Tasdelen E, Haessig S. Design and synthesis of selective and potent orally active S1P5 agonists. Chemmedchem. 5: 1693-6. PMID 20815011 DOI: 10.1002/cmdc.201000253  1
2010 Mattes H, Dev KK, Bouhelal R, Barske C, Gasparini F, Guerini D, Mir AK, Orain D, Osinde M, Picard A, Dubois C, Tasdelen E, Haessig S. Design and synthesis of selective and potent orally active S1P5 agonists (Chemical Medicine and Medicinal Chemistry (2010) 5, (1693-1696)) Chemmedchem. 5: 1646. DOI: 10.1002/cmdc.201090046  1
2009 Chatterjee S, Szustakowski JD, Nanguneri NR, Mickanin C, Labow MA, Nohturfft A, Dev KK, Sivasankaran R. Identification of novel genes and pathways regulating SREBP transcriptional activity. Plos One. 4: e5197. PMID 19381295 DOI: 10.1371/journal.pone.0005197  1
2008 Senechal Y, Prut L, Kelly PH, Staufenbiel M, Natt F, Hoyer D, Wiessner C, Dev KK. Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNA. Brain Research. 1243: 124-33. PMID 18823960 DOI: 10.1016/j.brainres.2008.09.024  1
2008 Osinde M, Clavaguera F, May-Nass R, Tolnay M, Dev KK. Lentivirus Tau (P301S) expression in adult amyloid precursor protein (APP)-transgenic mice leads to tangle formation. Neuropathology and Applied Neurobiology. 34: 523-31. PMID 18282162 DOI: 10.1111/j.1365-2990.2008.00936.x  1
2008 Olson BL, Hock MB, Ekholm-Reed S, Wohlschlegel JA, Dev KK, Kralli A, Reed SI. SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes & Development. 22: 252-64. PMID 18198341 DOI: 10.1101/gad.1624208  1
2008 Dev KK, Mullershausen F, Mattes H, Kuhn RR, Bilbe G, Hoyer D, Mir A. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacology & Therapeutics. 117: 77-93. PMID 17961662 DOI: 10.1016/j.pharmthera.2007.08.005  1
2008 Senechal Y, Kelly PH, Dev KK. Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning. Behavioural Brain Research. 186: 126-32. PMID 17884188 DOI: 10.1016/j.bbr.2007.08.003  1
2008 Cryan JF, Dev KK. Chapter 4.4 The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders Handbook of Behavioral Neuroscience. 17: 269-301. DOI: 10.1016/S1569-7339(07)00013-6  1
2007 Senechal Y, Kelly PH, Cryan JF, Natt F, Dev KK. Amyloid precursor protein knockdown by siRNA impairs spontaneous alternation in adult mice. Journal of Neurochemistry. 102: 1928-40. PMID 17540010 DOI: 10.1111/j.1471-4159.2007.04672.x  1
2007 Mullershausen F, Craveiro LM, Shin Y, Cortes-Cros M, Bassilana F, Osinde M, Wishart WL, Guerini D, Thallmair M, Schwab ME, Sivasankaran R, Seuwen K, Dev KK. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. Journal of Neurochemistry. 102: 1151-61. PMID 17488279 DOI: 10.1111/j.1471-4159.2007.4629.x  1
2007 Osinde M, Mullershausen F, Dev KK. Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology. 52: 1210-8. PMID 17379261 DOI: 10.1016/j.neuropharm.2006.11.010  1
2007 Dev KK. PDZ domain protein-protein interactions: a case study with PICK1. Current Topics in Medicinal Chemistry. 7: 3-20. PMID 17266593 DOI: 10.2174/156802607779318343  1
2007 Mahé C, Loetscher E, Dev KK, Bobirnac I, Otten U, Schoeffter P. Corrigendum to "Serotonin 5-HT7 receptors coupled to introduction of interleukin-6 in human microglial MC-3 cells" [Neuropharmacology 49 (2005) 40-47] (DOI:10.1016/j.neuropharm.2005.01.025) Neuropharmacology. 52: 1196. DOI: 10.1016/j.neuropharm.2006.08.019  1
2006 Dev KK, Henley JM. The schizophrenic faces of PICK1. Trends in Pharmacological Sciences. 27: 574-9. PMID 17011050 DOI: 10.1016/j.tips.2006.09.007  1
2006 Senechal Y, Larmet Y, Dev KK. Unraveling in vivo functions of amyloid precursor protein: insights from knockout and knockdown studies. Neuro-Degenerative Diseases. 3: 134-47. PMID 16954700 DOI: 10.1159/000094772  1
2006 Dev KK, Chatterjee S, Osinde M, Stauffer D, Morgan H, Kobialko M, Dengler U, Rueeger H, Martoglio B, Rovelli G. Signal peptide peptidase dependent cleavage of type II transmembrane substrates releases intracellular and extracellular signals. European Journal of Pharmacology. 540: 10-7. PMID 16697367 DOI: 10.1016/j.ejphar.2006.04.011  1
2006 Dev KK. Using RNAi in the clinic. Idrugs : the Investigational Drugs Journal. 9: 279-82. PMID 16596482  1
2006 Hoyer D, Dev KK. RNA interference as a therapeutic strategy for treating CNS disorders Drug Discovery Today: Therapeutic Strategies. 3: 451-456. DOI: 10.1016/j.ddstr.2006.10.008  1
2005 Mahé C, Loetscher E, Dev KK, Bobirnac I, Otten U, Schoeffter P. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. Neuropharmacology. 49: 40-7. PMID 15992579 DOI: 10.1016/j.neuropharm.2005.01.025  1
2005 Madsen KL, Beuming T, Niv MY, Chang CW, Dev KK, Weinstein H, Gether U. Molecular determinants for the complex binding specificity of the PDZ domain in PICK1. The Journal of Biological Chemistry. 280: 20539-48. PMID 15774468 DOI: 10.1074/jbc.M500577200  1
2004 Dev KK. Making protein interactions druggable: targeting PDZ domains. Nature Reviews. Drug Discovery. 3: 1047-56. PMID 15573103 DOI: 10.1038/nrd1578  1
2004 Friedmann E, Lemberg MK, Weihofen A, Dev KK, Dengler U, Rovelli G, Martoglio B. Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. The Journal of Biological Chemistry. 279: 50790-8. PMID 15385547 DOI: 10.1074/jbc.M407898200  1
2004 Mahé C, Bernhard M, Bobirnac I, Keser C, Loetscher E, Feuerbach D, Dev KK, Schoeffter P. Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. British Journal of Pharmacology. 143: 404-10. PMID 15339860 DOI: 10.1038/sj.bjp.0705936  1
2004 Dev KK, Nakanishi S, Henley JM. The PDZ domain of PICK1 differentially accepts protein kinase C-alpha and GluR2 as interacting ligands. The Journal of Biological Chemistry. 279: 41393-7. PMID 15247289 DOI: 10.1074/jbc.M404499200  1
2004 Terashima A, Cotton L, Dev KK, Meyer G, Zaman S, Duprat F, Henley JM, Collingridge GL, Isaac JT. Regulation of synaptic strength and AMPA receptor subunit composition by PICK1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5381-90. PMID 15190111 DOI: 10.1523/JNEUROSCI.4378-03.2004  1
2003 Dev KK, Hofele K, Barbieri S, Buchman VL, van der Putten H. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology. 45: 14-44. PMID 12814657 DOI: 10.1016/S0028-3908(03)00140-0  1
2003 Dev KK, van der Putten H, Sommer B, Rovelli G. Part I: parkin-associated proteins and Parkinson's disease. Neuropharmacology. 45: 1-13. PMID 12814656 DOI: 10.1016/S0028-3908(02)00337-4  1
2003 Cho K, Francis JC, Hirbec H, Dev K, Brown MW, Henley JM, Bashir ZI. Regulation of kainate receptors by protein kinase C and metabotropic glutamate receptors. The Journal of Physiology. 548: 723-30. PMID 12640005 DOI: 10.1113/jphysiol.2003.040188  1
2003 Finney N, Walther F, Mantel PY, Stauffer D, Rovelli G, Dev KK. The cellular protein level of parkin is regulated by its ubiquitin-like domain. The Journal of Biological Chemistry. 278: 16054-8. PMID 12621021 DOI: 10.1074/jbc.C300051200  1
2003 Hirbec H, Francis JC, Lauri SE, Braithwaite SP, Coussen F, Mulle C, Dev KK, Coutinho V, Meyer G, Isaac JT, Collingridge GL, Henley JM, Couthino V. Rapid and differential regulation of AMPA and kainate receptors at hippocampal mossy fibre synapses by PICK1 and GRIP. Neuron. 37: 625-38. PMID 12597860 DOI: 10.1016/S0896-6273(02)01191-1  1
2002 Hirbec H, Perestenko O, Nishimune A, Meyer G, Nakanishi S, Henley JM, Dev KK. The PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor subtypes. Analysis of PDZ binding motifs. The Journal of Biological Chemistry. 277: 15221-4. PMID 11891216 DOI: 10.1074/jbc.C200112200  1
2001 Dev KK, Nakanishi S, Henley JM. Regulation of mglu(7) receptors by proteins that interact with the intracellular C-terminus. Trends in Pharmacological Sciences. 22: 355-61. PMID 11431030 DOI: 10.1016/S0165-6147(00)01684-9  1
2001 Vernon E, Meyer G, Pickard L, Dev K, Molnar E, Collingridge GL, Henley JM. GABA(B) receptors couple directly to the transcription factor ATF4. Molecular and Cellular Neurosciences. 17: 637-45. PMID 11312600 DOI: 10.1006/mcne.2000.0960  1
2000 Daw MI, Chittajallu R, Bortolotto ZA, Dev KK, Duprat F, Henley JM, Collingridge GL, Isaac JT. PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron. 28: 873-86. PMID 11163273 DOI: 10.1016/S0896-6273(00)00160-4  1
2000 Dev KK, Nakajima Y, Kitano J, Braithwaite SP, Henley JM, Nakanishi S. PICK1 interacts with and regulates PKC phosphorylation of mGLUR7. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 7252-7. PMID 11007882  1
1999 Keir MJ, Barakat MJ, Dev KK, Bittiger H, Bettler B, Henley JM. Characterisation and partial purification of the GABA(B) receptor from the rat cerebellum using the novel antagonist [3H]CGP 62349. Brain Research. Molecular Brain Research. 71: 279-89. PMID 10521582 DOI: 10.1016/S0169-328X(99)00199-0  1
1999 Dev KK, Nishimune A, Henley JM, Nakanishi S. The protein kinase C alpha binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits. Neuropharmacology. 38: 635-44. PMID 10340301 DOI: 10.1016/S0028-3908(98)00230-5  1
1998 Dev KK, Honoré T, Henley JM. Different effects of phospholipase A2 on agonist binding to hippocampal, cortical and recombinant homomeric alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Neuroscience Letters. 246: 25-8. PMID 9622199 DOI: 10.1016/S0304-3940(98)00200-6  1
1997 Chittajallu R, Dev KK, Henley JM. Effect of thiol group modification on 3[H]-NBQX binding in rat cortical membranes. Biochemical Society Transactions. 25: 538S. PMID 9388752  1
1997 Dev KK, Honoré T, Henley JM. Effects of phospholipase A2 on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits. Biochemical Society Transactions. 25: 537S. PMID 9388751  1
1997 Dev KK, Foged C, Andersen H, Honoré T, Henley JM. High-affinity binding sites for 125I-labelled pancreatic secretory phospholipase A2 in rat brain. Brain Research. Molecular Brain Research. 49: 120-6. PMID 9387871 DOI: 10.1016/S0169-328X(97)00134-4  1
1996 Dev KK, Roberts PJ, Henley JM. Characterisation of the interaction between guanyl nucleotides and AMPA receptors in rat brain. Neuropharmacology. 35: 1583-93. PMID 9025106 DOI: 10.1016/S0028-3908(96)00123-2  1
1996 Dev KK, Petersen V, Honoré T, Henley JM. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain. Journal of Neurochemistry. 67: 2609-12. PMID 8931496  1
1996 Chittajallu R, Vignes M, Dev KK, Barnes JM, Collingridge GL, Henley JM. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature. 379: 78-81. PMID 8538745 DOI: 10.1038/379078a0  1
1995 Dev KK, Honoré T, Henley JM. Phospholipase A2 down-regulates the affinity of [3H]AMPA binding to rat cortical membranes. Journal of Neurochemistry. 65: 184-91. PMID 7540662  1
1994 Barnes JM, Dev KK, Henley JM. Cyclothiazide unmasks AMPA-evoked stimulation of [3H]-L-glutamate release from rat hippocampal synaptosomes. British Journal of Pharmacology. 113: 339-41. PMID 7530567  1
1994 Dev KK, Morris BJ. Modulation of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) binding sites by nitric oxide. Journal of Neurochemistry. 63: 946-52. PMID 7519666  1
Show low-probability matches.